Intercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences
February 17 2017 - 7:05AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that it will report its fourth quarter and full year 2016
financial results prior to the NASDAQ market open on Thursday,
February 23, 2017. Intercept management will conduct a conference
call and audio webcast on Thursday, February 23, 2017 at 8:30 a.m.
Eastern Time to discuss these results.
Intercept management will also be presenting at the following
investor conferences:
- 2017 RBC Capital Markets Global Healthcare Conference on
February 23, 2017 at 11:30 a.m. Eastern Time
- 37th Annual Cowen Health Care Conference on March 6, 2017 at
4:40 p.m. Eastern Time
Webcast information for these events will be available on the
Investors page of Intercept's website at
http://ir.interceptpharma.com. Archived webcasts will be available
on Intercept's website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC), nonalcoholic
steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and
biliary atresia. Founded in 2002 in New York, Intercept now has
operations in the United States, Europe and Canada.
CONTACT: For more information about
Intercept Pharmaceuticals, please contact:
Intercept Pharmaceuticals:
Mark Vignola
+1-646-747-1000
investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Investor inquiries: investors@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024